Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Peg-interferon alfa-2a |
Trade Name | Pegasys |
Synonyms | peginterferon alfa-2a|pegylated interferon alfa-2a|PEG-IFNA2a |
Drug Descriptions |
Pegasys (peg-interferon alfa-2a) comprises interferon alfa-2a conjugated to polyethylene glycol (PEG), which may decrease tumor cell proliferation and enhance anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | 198153-51-4 |
NCIT ID | C33987 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Bevacizumab + Peg-interferon alfa-2a | Atezolizumab Bevacizumab Peg-interferon alfa-2a | 0 | 1 |
Atezolizumab + Peg-interferon alfa-2a | Atezolizumab Peg-interferon alfa-2a | 0 | 1 |
Cemiplimab + Peg-interferon alfa-2a | Cemiplimab Peg-interferon alfa-2a | 0 | 1 |
Peg-interferon alfa-2a | Peg-interferon alfa-2a | 0 | 0 |